why choose us

First received: August 16, 2023

Clinical Trial: Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Study Status: Completed

Recruit Status: RECRUITING

Condition: Fibrosis, Liver

Study Type: INTERVENTIONAL


Official Title: Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Brief Summary: Conduct a community intervention study that will 1) validate a screening approach to identify patients at risk for advanced NAFLD in the obese or T2DM population, and 2) test whether semaglutide treatment is effective for the management of significant fibrosis due to NAFLD in high-risk patients.

Read more